Published in J Ther Ultrasound on February 29, 2016
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (1989) 3.32
Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke (1985) 2.89
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci (2007) 2.77
Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res (2001) 2.30
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke (2008) 2.23
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Coronary vasodilation by noninvasive transcutaneous ultrasound: an in vivo canine study. J Am Coll Cardiol (2003) 2.06
Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide (2009) 2.00
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2000) 1.94
Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2004) 1.88
Molecular mechanisms underlying the activation of eNOS. Pflugers Arch (2009) 1.84
Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal (2003) 1.81
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol (2014) 1.73
Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev (2009) 1.61
Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab (2006) 1.60
Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2005) 1.56
The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2014) 1.52
Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal (2006) 1.50
Nitric oxide and neuronal death. Nitric Oxide (2010) 1.49
Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab (1998) 1.46
Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations. Neurosurgery (1978) 1.45
Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab (1998) 1.44
RUPTURED INTRACRANIAL ANEURYSMS--THE ROLE OF ARTERIAL SPASM. J Neurosurg (1965) 1.20
Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? Neurosurg Focus (2006) 1.19
Blast-induced brain injury and posttraumatic hypotension and hypoxemia. J Neurotrauma (2009) 1.19
Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol (2010) 1.15
Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery (2003) 1.13
Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg (1976) 1.11
A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg (1993) 1.11
Simvastatin in subarachnoid haemorrhage: beyond the short-term. Lancet Neurol (2014) 1.10
Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir (Wien) (1986) 1.07
A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg (2010) 1.05
Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage. J Neurotrauma (2009) 1.01
Ultrasound improves tissue perfusion in ischemic tissue through a nitric oxide dependent mechanism. Thromb Haemost (2002) 0.98
Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front Physiol (2013) 0.98
Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis. J Thromb Haemost (2004) 0.97
Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg (1996) 0.97
Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery (2005) 0.96
SUBARACHNOID HEMORRHAGE--FACTORS IN PROGNOSIS AND MANAGEMENT. J Neurosurg (1964) 0.95
Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg (1996) 0.94
Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Ann Neurol (2002) 0.93
In vivo bubble nucleation probability in sheep brain tissue. Phys Med Biol (2011) 0.92
Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage. Stroke (2007) 0.92
Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke (1999) 0.92
The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States. Neurosurgery (2013) 0.91
Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg (1988) 0.91
Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl (2008) 0.89
Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery (2010) 0.88
Cerebral blood flow regulation by nitric oxide in neurological disorders. Can J Physiol Pharmacol (2009) 0.88
Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir (Wien) (1994) 0.88
Progress in sonothrombolysis for the treatment of stroke. Stroke (2012) 0.87
Noninvasive low-frequency ultrasound energy causes vasodilation in humans. J Am Coll Cardiol (2006) 0.86
What's new in the cerebral microcirculation? Landis Award lecture. Microcirculation (2001) 0.86
Endovascular management of cerebral vasospasm. Neurosurgery (2006) 0.85
Bioeffect of ultrasound on endothelial cells in vitro. Biomol Eng (2004) 0.83
The neuropathology of the vegetative state and severe disability after non-missile head injury. Acta Neurochir Suppl (Wien) (1983) 0.83
Taboos and opportunities in sonothrombolysis for stroke. Int J Hyperthermia (2012) 0.82
Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery (1983) 0.81
Comparison of postoperative cognitive function in patients undergoing surgery for ruptured and unruptured intracranial aneurysm. Surg Neurol (2009) 0.81
Impairment of intracerebral arteriole dilation responses after subarachnoid hemorrhage. Laboratory investigation. J Neurosurg (2009) 0.81
Nitric oxide generation directly responds to ultrasound exposure. Ultrasound Med Biol (2007) 0.80
Low-Power 2-MHz Pulsed-Wave Transcranial Ultrasound Reduces Ischemic Brain Damage in Rats. Transl Stroke Res (2011) 0.78
Early iNOS impairment and late eNOS enhancement during reperfusion following 2.49 MHz continuous ultrasound exposure after ischemia. Ultrason Sonochem (2008) 0.76
Ultrasound stimulates formation and release of vasoactive compounds in brain endothelial cells. Am J Physiol Heart Circ Physiol (2015) 0.76